| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-1-4939-6515-1_2 |
| P698 | PubMed publication ID | 27837497 |
| P50 | author | Christianne Micallef | Q56450804 |
| P2093 | author name string | David A Enoch | |
| Huina Yang | |||
| Sani H Aliyu | |||
| P2860 | cites work | Global Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An Atlas of the Molecular Types | Q21284793 |
| Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients | Q24193204 | ||
| A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada) | Q24558831 | ||
| Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study | Q24606804 | ||
| Infections caused by Scedosporium spp. | Q24657691 | ||
| Cryptococcus gattii infections | Q27002687 | ||
| An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction | Q28276188 | ||
| An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? | Q28296417 | ||
| Nosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospital | Q28541447 | ||
| Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance | Q28545137 | ||
| Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy | Q28740362 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study | Q29616607 | ||
| Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS | Q29617372 | ||
| Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. | Q30332334 | ||
| Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. | Q30453032 | ||
| Invasive aspergillosis in a paediatric haematology department: a 15-year review | Q37078397 | ||
| Clinical and epidemiological aspects of infections caused by fusarium species: a collaborative study from Israel | Q37157656 | ||
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
| Seasonal variations in the clinical presentation of pulmonary and extrapulmonary blastomycosis | Q37225468 | ||
| Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection. | Q37302602 | ||
| Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii | Q37305589 | ||
| Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. | Q37313058 | ||
| Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain | Q37336194 | ||
| Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa | Q37347385 | ||
| Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature | Q37474014 | ||
| Clinical findings in 19 cases of invasive pulmonary aspergillosis with liver cirrhosis | Q37479561 | ||
| SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. | Q37530914 | ||
| Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital | Q37537198 | ||
| Incidence of zygomycosis in transplant recipients | Q37597541 | ||
| Outbreaks of zygomycosis in hospitals | Q37597551 | ||
| Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature | Q37679217 | ||
| Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil | Q37734169 | ||
| Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review | Q37783462 | ||
| Epidemiology of invasive fungal infections in neonates and children | Q37788797 | ||
| Blastomycosis in children and adolescents: a 30-year experience from Manitoba | Q37826183 | ||
| Pneumocystis jirovecii pneumonia in developing countries | Q37926917 | ||
| Risk factors for persistent candidemia infection in a neonatal intensive care unit and its effect on mortality and length of hospitalization | Q37955071 | ||
| Trends in the prevalence of invasive fungal infections from an analysis of annual records of autopsy cases of Toho University. | Q37982759 | ||
| Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients | Q38050109 | ||
| Skin lesions in histoplasmosis | Q38052201 | ||
| Systemic fungal infections in patients with human inmunodeficiency virus | Q38056310 | ||
| Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports. | Q38057643 | ||
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. | Q38058556 | ||
| Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care | Q38073717 | ||
| Ten-year review of candidemia in a Canadian tertiary care centre: Predominance of non-albicans Candida species | Q38178257 | ||
| Predictors and outcomes of Candida bloodstream infection: eight-year surveillance, western Saudi Arabia | Q38182328 | ||
| Genomics in Coccidioides: insights into evolution, ecology, and pathogenesis | Q38191763 | ||
| Mucormycosis in India: unique features | Q38245969 | ||
| Risk factors for mortality in patients with mucormycosis | Q38261678 | ||
| Preventing invasive candida infections. Where could we do better? | Q38320016 | ||
| The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. | Q38412398 | ||
| Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. | Q44582257 | ||
| Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients | Q44599233 | ||
| Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China | Q44856161 | ||
| Nosocomial bloodstream infections in United States hospitals: a three-year analysis | Q44863798 | ||
| Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required | Q44964107 | ||
| Surveillance study of candidemia in cancer patients in North China | Q44976855 | ||
| Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit | Q45015416 | ||
| Three cases of cutaneous mucormycosis with Lichtheimia spp. (ex Absidia/Mycocladus) in ICU. Possible cross-transmission in an intensive care unit between 2 cases. | Q45019919 | ||
| Epidemiology and outcomes of bloodstream infection in patients with cirrhosis | Q45227643 | ||
| Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry | Q45374123 | ||
| Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis. | Q45402665 | ||
| Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus | Q45745472 | ||
| Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. | Q45938423 | ||
| Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis. | Q46053133 | ||
| Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors | Q46098829 | ||
| Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India | Q46120491 | ||
| Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital. | Q46352708 | ||
| Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia | Q46613311 | ||
| Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade | Q46876396 | ||
| Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy? | Q46908055 | ||
| Invasive Candidiasis in preterm neonates in China: a retrospective study from 11 NICUS during 2009-2011. | Q46979134 | ||
| An outbreak of Pneumocystis carinii pneumonia in children with malignancy. | Q48142270 | ||
| Burden of aspergillosis-related hospitalizations in the United States. | Q50508010 | ||
| Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. | Q50700185 | ||
| Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. | Q50917195 | ||
| Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients. | Q50927538 | ||
| Candidaemia in a European Paediatric University Hospital: a 10-year observational study. | Q50984327 | ||
| A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. | Q51168535 | ||
| Clinical characteristics and prognosis of chronic pulmonary aspergillosis. | Q51173069 | ||
| Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009. | Q51174005 | ||
| Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States | Q30489026 | ||
| Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008. | Q30574840 | ||
| Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: a 4-year survey | Q30841261 | ||
| Infrequent detection of Pneumocystis jirovecii by PCR in oral wash specimens from TB patients with or without HIV and healthy contacts in Tanzania | Q30983646 | ||
| Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai | Q33661367 | ||
| Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009-2010 | Q33798413 | ||
| Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 years | Q33807195 | ||
| Population-based analysis of invasive fungal infections, France, 2001-2010. | Q33816423 | ||
| First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain | Q33885239 | ||
| Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy | Q33894498 | ||
| Incidence and predictors of invasive candidiasis associated with candidaemia in children | Q33926760 | ||
| Cryptococcus laurentii fungemia in a premature neonate | Q33972041 | ||
| Comparison of albicans vs. non-albicans candidemia in French intensive care units | Q34026915 | ||
| Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome | Q34036214 | ||
| Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010) | Q34100598 | ||
| Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellanii | Q34147181 | ||
| Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital | Q34221581 | ||
| The Danish Collaborative Bacteraemia Network (DACOBAN) database. | Q34229737 | ||
| Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. | Q34243482 | ||
| Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period | Q34252030 | ||
| The changing epidemiology of healthcare-associated candidemia over three decades | Q34266632 | ||
| Epidemiology of Candida species infections in critically ill non-immunosuppressed patients | Q34273626 | ||
| Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. | Q34315776 | ||
| The epidemiological profile of candidemia at an Indian trauma care center | Q34335391 | ||
| Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. | Q34372192 | ||
| Multistate point-prevalence survey of health care-associated infections | Q34412128 | ||
| Epidemiology and outcome of zygomycosis: a review of 929 reported cases | Q34440240 | ||
| Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. | Q34455633 | ||
| Candida and host determinants of susceptibility to invasive candidiasis | Q34539797 | ||
| Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes | Q34559978 | ||
| The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study | Q34586566 | ||
| Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment | Q34610528 | ||
| Epidemiology of candidemia in Latin America: a laboratory-based survey | Q34635088 | ||
| Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation | Q38419604 | ||
| Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France | Q38540401 | ||
| Improvement in the Outcome of Invasive Aspergillosis in a Pediatric Hematology Department: A 10-Year Review. | Q38545524 | ||
| Pneumocystis carinii in children with severe pneumonia at Mulago Hospital, Uganda | Q38881616 | ||
| Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima, Peru. | Q38927031 | ||
| Pneumocystis carinii is not a major cause of pneumonia in HIV infected patients in Lusaka, Zambia | Q38993008 | ||
| Predisposing factors for candidemia in patients with major burns. | Q39006972 | ||
| Characteristics of invasive aspergillosis in neutropenic haematology patients (Sousse, Tunisia). | Q39022120 | ||
| Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt | Q39062203 | ||
| Incidence, characteristics and outcome of ICU-acquired candidemia in India | Q39092143 | ||
| Fungemia caused by Candida species in a children's public hospital in the city of São Paulo, Brazil: study in the period 2007-2010. | Q39322474 | ||
| Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors? | Q39438349 | ||
| Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela | Q39465160 | ||
| Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study | Q39508090 | ||
| Risk factors for fluconazole-resistant candidemia | Q39934814 | ||
| Septic shock attributed to Candida infection: importance of empiric therapy and source control | Q40026437 | ||
| Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease: a single-centre retrospective analysis of 52 subjects | Q40271865 | ||
| Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. | Q40524039 | ||
| Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010. | Q40757551 | ||
| Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009). | Q40760873 | ||
| A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. | Q40833322 | ||
| Candida Bloodstream Infections in Italy: Changing Epidemiology during 16 Years of Surveillance | Q40845928 | ||
| Significance of yeasts in bloodstream infection: Epidemiology and predisposing factors of Candidaemia in adult patients at a university hospital (2010-2014). | Q40917086 | ||
| Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Coinfection Among Adults With Candidemia in Atlanta, GA, 2008-2012. | Q41031797 | ||
| Invasive Fungal Infections After Kidney Transplantation: A Single-center Experience. | Q41189447 | ||
| Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China | Q41226605 | ||
| Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). | Q41337245 | ||
| Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. | Q41384733 | ||
| Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain | Q41471270 | ||
| Candidaemia in a paediatric centre and importance of central venous catheter removal | Q41485456 | ||
| Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008). | Q41503949 | ||
| Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis. | Q41532401 | ||
| Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group. | Q41582315 | ||
| Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time. | Q41688144 | ||
| Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients. | Q41700108 | ||
| Epidemiology and prognostic factors of candidemia in elderly patients | Q41726019 | ||
| Fungal infections after liver transplantation: incidence and outcome. | Q41731015 | ||
| Clinical and epidemiological characteristics and risk factors for mortality in patients with candidemia in hospitals from Bogotá, Colombia | Q41757647 | ||
| Epidemiology and clinical features of post-transplant bloodstream infection: an analysis of 222 consecutive liver transplant recipients | Q41852962 | ||
| Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients | Q42175368 | ||
| Mucormycosis outbreak associated with hospital linens | Q42222305 | ||
| Invasive aspergillosis among heart transplant recipients: a 24-year perspective | Q42227448 | ||
| Neonatal invasive fungal infection in England 2004-2010. | Q42230460 | ||
| Characteristics of Pneumocystis pneumonia in Nancy from January 2007 to April 2011 and focus on an outbreak in nephrology. | Q42234323 | ||
| Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities | Q42242152 | ||
| Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis | Q42243344 | ||
| Changing epidemiology of candidemia in a medical center in middle Taiwan. | Q42244889 | ||
| A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering | Q42260280 | ||
| Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan | Q42260420 | ||
| Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study | Q42268319 | ||
| Candidemia among adults in Soweto, South Africa, 1990-2007. | Q42269027 | ||
| Candidaemia in Sweden: a nationwide prospective observational survey | Q42278206 | ||
| Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. | Q42286809 | ||
| Declining incidence of candidemia in a tertiary inpatient pediatric population | Q42597625 | ||
| Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings | Q34918287 | ||
| The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of 236 autopsied cases in mumbai, India | Q35025853 | ||
| Emerging and less common fungal pathogens | Q35038469 | ||
| Etiology of suspected pneumonia in adults admitted to a high-dependency unit in Blantyre, Malawi | Q35065611 | ||
| Hormones and the resistance of women to paracoccidioidomycosis. | Q35066007 | ||
| Candidemia surveillance in Iowa: emergence of echinocandin resistance | Q35130682 | ||
| Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes | Q35131913 | ||
| Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia | Q35192301 | ||
| Increasing Prevalence of Trichophyton rubrum Identified through an Analysis of 115,846 Cases over the Last 37 Years | Q35553743 | ||
| Clinical and therapeutic aspects of candidemia: a five year single centre study. | Q35641217 | ||
| Causes of early mortality in HIV-infected TB suspects in an East African referral hospital. | Q35645111 | ||
| Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study | Q35716788 | ||
| Invasive fungal infections in patients with hematologic malignancies (aurora project): lights and shadows during 18-months surveillance | Q35719482 | ||
| Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives | Q35746962 | ||
| Opportunistic Infections among People Living with HIV (PLHIV) with Diabetes Mellitus (DM) Attending a Tertiary Care Hospital in Coastal City of South India | Q35750218 | ||
| Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. | Q35765997 | ||
| Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia | Q35841375 | ||
| Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience | Q35848669 | ||
| Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. | Q35848794 | ||
| Molecular evidence of Pneumocystis transmission in pediatric transplant unit | Q35873325 | ||
| Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases | Q35905124 | ||
| Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection | Q35941512 | ||
| Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children | Q35973408 | ||
| The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial | Q36058200 | ||
| Risk factors for invasive fungal disease in critically ill adult patients: a systematic review | Q36073057 | ||
| Rapid development of Candida krusei echinocandin resistance during caspofungin therapy | Q36158489 | ||
| Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis | Q36216209 | ||
| Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features | Q36229310 | ||
| Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility. | Q36237993 | ||
| Autochthonous and dormant Cryptococcus gattii infections in Europe | Q36318438 | ||
| A Prospective, International Cohort Study of Invasive Mold Infections in Children. | Q36377386 | ||
| Overview and perspectives the transcriptome of Paracoccidioides brasiliensis | Q36405490 | ||
| Pneumocystis pneumonia in patients treated with rituximab | Q36411232 | ||
| Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. | Q36423773 | ||
| Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients. | Q36434403 | ||
| Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature | Q36573951 | ||
| Blastomycosis in a South Indian patient after visiting an endemic area in USA. | Q36590944 | ||
| Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection | Q36642119 | ||
| Radiological and clinical findings of 25 patients with invasive pulmonary aspergillosis: retrospective analysis of 2150 liver transplantation cases | Q36653238 | ||
| Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011 | Q36667530 | ||
| Ecological niche modeling of Coccidioides spp. in western North American deserts | Q36775008 | ||
| Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations | Q36856930 | ||
| Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project) | Q36898053 | ||
| Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment | Q36925843 | ||
| Zygomycosis in children: a systematic review and analysis of reported cases | Q36937857 | ||
| Coccidioidomycosis and other endemic mycoses in Mexico | Q37038737 | ||
| Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. | Q37055188 | ||
| Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors | Q43119766 | ||
| Forty-one recent cases of invasive zygomycosis from a global clinical registry. | Q43223060 | ||
| Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil | Q43427231 | ||
| Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study | Q43631437 | ||
| Candidaemia in a Polish tertiary paediatric hospital, 2000 to 2010. | Q43802612 | ||
| Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). | Q44020369 | ||
| Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009. | Q44073369 | ||
| Histoplasmosis in a Brazilian center: clinical forms and laboratory tests | Q44188539 | ||
| Candidemia: incidence rates, type of species, and risk factors at a tertiary care academic hospital in China | Q44200469 | ||
| Management and outcome of bloodstream infections due to Candida species in England and Wales | Q44454722 | ||
| Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. | Q51180154 | ||
| Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. | Q51184875 | ||
| The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. | Q51188122 | ||
| The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. | Q53195957 | ||
| Epidemiology and predictors of a poor outcome in elderly patients with candidemia | Q56970458 | ||
| Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients | Q57208471 | ||
| INVASIVE ASPERGILLOSIS IN INTENSIVE CARE UNIT PATIENTS IN IRAN | Q57252848 | ||
| Trends in Hospitalizations for AIDS-Associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005) | Q58061947 | ||
| Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 | Q58405315 | ||
| Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010 | Q58815228 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| invasive fungal infections | Q55022218 | ||
| P304 | page(s) | 17-65 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Methods in Molecular Biology | Q15752859 |
| P1476 | title | The Changing Epidemiology of Invasive Fungal Infections | |
| P478 | volume | 1508 |
| Q98158478 | A Cytoplasmic Heme Sensor Illuminates the Impacts of Mitochondrial and Vacuolar Functions and Oxidative Stress on Heme-Iron Homeostasis in Cryptococcus neoformans |
| Q58822253 | Butenafine and analogues: An expeditious synthesis and cytotoxicity and antifungal activities |
| Q38806932 | Combination therapy for the treatment of pulmonary mold infections |
| Q55471038 | Diagnostic Aspects of Veterinary and Human Aspergillosis. |
| Q38798805 | Drug development challenges and strategies to address emerging and resistant fungal pathogens |
| Q39375330 | Drugs currently under investigation for the treatment of invasive candidiasis |
| Q64948530 | Epidemiology and Clinical Features of Invasive Fungal Infection in a US Health Care Network. |
| Q55544506 | Epidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990-2015. |
| Q90750227 | Essential Oils and Their Natural Active Compounds Presenting Antifungal Properties |
| Q38646284 | Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study |
| Q40043020 | Fungal Infections of the Central Nervous System in Children |
| Q40045680 | Future Research Priorities in Fungal Resistance |
| Q89885707 | Hope on the Horizon: Novel Fungal Treatments in Development |
| Q50234398 | Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida. |
| Q89977631 | Immunotherapy against Systemic Fungal Infections Based on Monoclonal Antibodies |
| Q90101299 | Incorporation of 2-amino-thiophene derivative in nanoparticles: enhancement of antifungal activity |
| Q38614492 | Invasive candidiasis: future directions in non-culture based diagnosis |
| Q92446036 | Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy |
| Q47599546 | Matrix-assisted laser desorption/ionization-time of flight mass spectrometry: protocol standardization and database expansion for rapid identification of clinically important molds. |
| Q90393578 | Metabolomic-Based Methods in Diagnosis and Monitoring Infection Progression |
| Q52309400 | Multilocus Sequence Typing Reveals a New Cluster of Closely Related Candida tropicalis Genotypes in Italian Patients With Neurological Disorders. |
| Q48155956 | Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). |
| Q92626942 | Promising antifungal activity of new oxadiazole against Candida krusei |
| Q89965404 | Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody |
| Q89678252 | Rapid identification of clinical common invasive fungi via a multi-channel real-time fluorescent polymerase chain reaction melting curve analysis |
| Q89670980 | Rapid identification of the Candida glabrata species complex by high-resolution melting curve analysis |
| Q55453637 | Recent Advances in the Treatment of Scedosporiosis and Fusariosis. |
| Q33797083 | Scedosporium apiospermum brain abscesses in a patient after near-drowning - a case report with 10-year follow-up and a review of the literature |
| Q90663373 | Single-tube, dual channel pentaplexing for the identification of Candida strains associated with human infection |
| Q36396166 | Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis |
| Q61806029 | Sugar Sensing and Signaling in and |
| Q42372896 | Targeting the Immune System with Plant Lectins to Combat Microbial Infections |
| Q89551770 | The Squeaky Yeast Gets Greased: The Roles of Host Lipids in the Clearance of Pathogenic Fungi |
| Q58096339 | Therapy of Non-Dermatophytic Mycoses in Animals |
| Q90617644 | Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections |
| Q91750547 | Unusual and Highly Bioactive Sesterterpenes Synthesized by Pleurotus ostreatus during Coculture with Trametes robiniophila Murr |
| Q97090180 | Update on invasive fungal infections in the Middle Eastern and North African region |
| Q64059158 | study of 4-phosphorylated derivatives of 1,3-oxazole as inhibitors of fructose-1,6-bisphosphate aldolase II |
Search more.